Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England

K. E. Chapman, D. Wilson, Russell Gorton

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

The 7-valent pneumococcal conjugate vaccine (PCV7) has been included in the routine childhood immunization programme in the UK since September 2006. A population-based study of serotypes causing invasive pneumococcal disease (IPD) post-PCV7 in North East England was conducted using data from a regional enhanced IPD surveillance system. Overall, there was a 20% reduction [95% confidence interval (CI) 5-32] from 12·1 cases/100 000 population in 2006/2007 to 9·7 in 2009/2010. There was a fall in IPD caused by PCV7 serotypes in all age groups, with reductions of 90% (95% CI 61-99) in children aged <5 years, 50% (95% CI 4-75) in persons aged 5-64 years and 66% (95% CI 40-82) in adults aged

Original languageEnglish
Pages (from-to)344-352
Number of pages9
JournalEpidemiology and Infection
Volume141
Issue number2
DOIs
Publication statusPublished - Feb 2013

Keywords

  • Invasive pneumococcal disease
  • pneumococcal conjugate vaccine
  • Streptococcus pneumoniae (pneumococcus)

Fingerprint

Dive into the research topics of 'Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England'. Together they form a unique fingerprint.

Cite this